Headquartered in Brea, CA Fiscal year ends December NYSE: NVST envistaco.com
Envista Holdings Corporation is a global dental industry company that unites more than 30 trusted brands — including DEXIS, Kerr, Nobel Biocare, and Ormco — under a mission of partnering with dental professionals to improve patients' lives. The company operates through two reportable segments: Specialty Products & Technologies (encompassing dental implants, orthodontics, and digital imaging) and Equipment & Consumables (covering dental instruments, consumable products, and related equipment). Nobel Biocare is credited with introducing the first dental implant, Ormco is a pioneer in traditional and digital orthodontics, DEXIS specializes in 2D, 3D, and intraoral imaging, and Kerr has supported clinicians for over 135 years. The company's operational approach is driven by its proprietary Envista Business System (EBS), a continuous improvement framework that supports margin expansion and operational excellence. Envista serves dental professionals globally with a comprehensive portfolio of technologies, consumables, and services. Updated
Markets wobble heading into the Labor Day weekend as bond vigilantes push back against Washington, oil stays tense with Middle East strikes escalating, and Wall Street analysts make bold calls on names…
John Rogers built his fortune hunting unloved stocks that the market abandoned too soon, but three of his favorite contrarian bets look very different when filtered through the lens of retirement income…
With consumer sentiment sitting at 53.3 in March 2026, deep in pessimistic territory, retail investors are hunting for defensive names that can grow even as households tighten budgets. Healthcare keeps that promise.…
Wednesday's top analyst upgrades and downgrades included Bluebird Bio, Boeing, Coinbase Global, Costco Wholesale, Envista, Merck, New Fortress Energy, NexTier Oilfield Solutions, Radius Global Infrastructures, Regions Financial and Wayfair.
Envista Holdings Corporation is a global dental industry company that unites more than 30 trusted brands — including DEXIS, Kerr, Nobel Biocare, and Ormco — under a mission of partnering with dental professionals to improve patients' lives.
24/7 Wall St.'s 12-month price target for NVST is $31.31, rated Buy. The Wall Street consensus target is $28.69. NVST price prediction →
